Emergent files paperwork for new immuno-oncology spin-off

Friday, May 6, 2016 @ 2:42pm by BioPrepWatch Reports

Emergent BioSolutions announced April 15 that it has begun the formal process of separating some of its assets to form a separate entity, which will be known as Aptevo Therapeutics Inc.
Read More »

Smiths Detection secures $17.2 million Army contract for personal chemical detectors

Wednesday, May 4, 2016 @ 4:44pm by BioPrepWatch Reports

Smiths Detection Inc. will provide the U.S. Army with chemical detection devices as part of a $17.2 million contract with the U.S. Department of Defense (DOD).
Read More »

Emergent files application to expand production of BioThrax

Wednesday, Apr 27, 2016 @ 11:57am by Khristopher Flack

Emergent BioSolutions has filed a supplemental Biologics License Application with the U.S. Food and Drug Administration to scale up production of its anthrax vaccine BioThrax.
Read More »

House oversight subcommittee reports on safety of bioresearch labs

Thursday, Apr 21, 2016 @ 1:36pm by BioPrepWatch Reports

The House Energy and Commerce Subcommittee on Oversight and Investigations has released a report on its investigation of allegations that a bioresearch lab in Maryland mishandled vials of smallpox.
Read More »

New screening for anthrax-related meningitis developed by CDC

Saturday, Apr 16, 2016 @ 3:41pm by BioPrepWatch Reports

A development for the capability to screen a large group of people for anthrax-induced meningitis has recently been published in the 'Clinical Infectious Diseases' journal.
Read More »

FDA gives clearance for Great Basin E.coli test

Wednesday, Mar 30, 2016 @ 12:21pm by BioPrepWatch Reports

The U.S.
Read More »

ECBC offers support to Yuma Proving Ground study

Friday, Mar 25, 2016 @ 3:01pm by BioPrepWatch Reports

A team of researchers based with the U.S. Army Edgewood Chemical Biological Center (ECBC) was recently deployed to the Sonoran Desert in order to conduct studies on the U.S. Army Yuma Proving Ground.
Read More »

FDA approves new inhalational anthrax treatment

Friday, Mar 25, 2016 @ 2:59pm by BioPrepWatch Reports

Officials with the U.S. Food and Drug Administration (FDA) recently approved the Anthim (obiltoxaximab) injection, to be used with specific antibacterial drugs to treat people who have had inhalational anthrax.
Read More »

New antibody discovery may lead to effective Ebola treatment

Friday, Mar 11, 2016 @ 6:37pm by BioPrepWatch Reports

A newly discovered monoclonal antibody has been tested against the human Ebola virus in primates and has proven to protect primates against the Ebola virus, even up to five days after the initial infection.
Read More »

CBARR visits U.S. Army's Edgewood Center to prepare for joint mission

Wednesday, Mar 9, 2016 @ 6:32pm by BioPrepWatch Reports

At the end of 2015, the Chemical Biological Application and Risk Reduction Business Unit met at the U.S. Army's Edgewood Chemical Biological Center to collaborate on a forthcoming mission.
Read More »

Immunovaccine joins hunt for Zika vaccine

Saturday, Mar 5, 2016 @ 9:27am by BioPrepWatch Reports

The immunotherapy company Immunovaccine Inc. announced Thursday that it will puts its resources behind the global effort to develop an effective vaccine for the Zika virus.
Read More »

Synthetic Biologics receives three patent applications

Thursday, Mar 3, 2016 @ 7:49pm by BioPrepWatch Reports

Synthetic Biologics Inc. has received three patent applications for a microbiome designed to protect the gut.
Read More »

SIGA Technologies reaches final stages of smallpox drug trial

Tuesday, Mar 1, 2016 @ 7:53pm by BioPrepWatch Reports

SIGA Technologies has reached the final stages of its clinical trial for a drug that could cure small pox.
Read More »

DoD tests platform for nerve agent antidote

Friday, Feb 19, 2016 @ 6:01pm by BioPrepWatch Reports

The U.S. Department of Defense (DoD) has selected Emergard as a potential candidate for a nerve agent antidote delivery system.
Read More »

FDA issues new blood donation guidelines due to Zika threat

Thursday, Feb 18, 2016 @ 5:50pm by BioPrepWatch Reports

The U.S. Food and Drug Administration (FDA) has issued new guidelines for donating blood to travelers that have visited countries with outbreaks of the Zika virus.
Read More »

GenArraytion develops first test to identify Zika virus

Tuesday, Feb 2, 2016 @ 9:25pm by BioPrepWatch Reports

GenArraytion Inc. has created the first test capable of identifying the Zika virus and other mosquito-caused illnesses.
Read More »

University of Maryland researchers to work on Radiation Nuclear Model Development program

Tuesday, Jan 19, 2016 @ 3:35pm by BioPrepWatch Reports

Researchers at the University of Maryland School of Medicine will be working on the Radiation Nuclear Model Development program.
Read More »

Vaccine developed to beat dengue fever faces clinical trial

Saturday, Jan 16, 2016 @ 9:35am by BioPrepWatch Reports

Researchers in Brazil are launching a clinical trial for a vaccine they believe can prevent dengue fever, a potentially fatal disease transmitted by mosquitoes.
Read More »

University of Texas renames Center for Infectious Disease after late scientist

Saturday, Jan 16, 2016 @ 9:20am by BioPrepWatch Reports

Dr. John LaMontagne will have a research center named after him at the University of Texas.
Read More »

Malaria treatments ineffective against drug-resistant parasites in Cambodia

Monday, Jan 11, 2016 @ 4:26pm by BioPrepWatch Reports

Researchers from the NIAID, a branch of the NIH, found that the first-line malaria treatment being used in Cambodia is ineffective because the parasites have developed resistance.
Read More »